RALEIGH, N.C.--(BUSINESS WIRE)--Xerium Technologies, Inc. (NYSE:XRM - News), a leading global manufacturer of industrial textiles and rolls used primarily in the paper production process, today reported results for its third quarter ended September 30, 2009.
“While the global economy remains unstable, we are encouraged by some early signs of recovery in three of our four geographic operating regions, led by further reductions in customer inventory and improving prices for paper and pulp,” said Stephen R. Light, President, Chief Executive Officer and Chairman. “Our sales increased by approximately eight percent in the third quarter of 2009 as compared to the second quarter of 2009 while our gross margin as a percentage of sales remained essentially constant indicating pricing stability. While our near-term sales may not respond in the same manner as our booked future orders, an increase in such orders and discussions with many of our major customers indicate that they are feeling more positive about the future.”
“Our operational initiatives continue on plan with our new product and yield improvement programs gaining early traction, enabling us to shorten delivery lead times to our customers which we believe provides us a competitive advantage in our cash-challenged market. Having already significantly reduced our operating cost structure to better align with market realities, we remain focused on releasing additional ‘trapped cash’ from our balance sheet, shedding excess inventory and collecting aged receivables to generate cash.”
“We also continue to be fully engaged with our lenders working to resolve our debt issues.”
THIRD QUARTER FINANCIAL HIGHLIGHTS
OTHER DEVELOPMENTS
SEGMENT INFORMATION
The following table presents net sales for the third quarter of 2009 and 2008 by segment and the effect of currency on pricing and translation on third quarter 2009 net sales:
(dollars in millions):
|
Net Sales
|
Decrease |
Decrease in |
Percent decrease in net
|
|||||||||||||||||
|
2009 |
2008 |
Total |
Excluding |
|||||||||||||||||
| Clothing | $ | 86.0 | $ | 104.4 | $ | (18.4 | ) | $ | (2.8 | ) | (17.6 | )% | (14.9 | )% | ||||||
| Roll Covers | 44.3 | 54.9 | (10.6 | ) | (1.4 | ) | (19.3 | )% | (16.8 | )% | ||||||||||
| Total | $ | 130.3 | $ | 159.3 | $ | (29.0 | ) | $ | (4.2 | ) | (18.2 | )% | (15.6 | )% | ||||||
|
* Decrease in third quarter 2009 net sales due to currency translation is calculated by subtracting (i) an amount equal to net sales for the third quarter of 2008 from (ii) net sales for the third quarter of 2009 at the applicable average foreign currency exchange rate for the third quarter of 2009. |
||||||||||||||||||||
|
** Change in the third quarter 2009 net sales due to currency effect on pricing relates to sales prices indexed in U.S. Dollars by certain non-U.S. operations and is calculated based on the difference in the exchange rate from the time of pricing commitment to the customer and the point at which the sale transaction is recorded. |
||||||||||||||||||||
CONFERENCE CALL
The Company plans to hold a conference call to discuss these results tomorrow morning:
| Date: | Friday, November 6, 2009 | |
| Start Time: | 8:00 a.m. Eastern Time | |
| Domestic Dial-In: | +1-888-396-2369 | |
| International Dial-In: | +1-617-847-8710 | |
| Passcode: | 55836412 | |
| Webcast & Slide Presentation: | ||
To participate on the call, please dial in at least 10 minutes prior to the scheduled start. A live audio webcast and replay of the call, in addition to a slide presentation, may be found in the investor relations section of the company’s website at www.xerium.com.
NON-GAAP FINANCIAL MEASURES
This press release includes measures of performance that differ from the Company’s financial results as reported under generally accepted accounting principles (“GAAP”). The Company uses supplementary non-GAAP measures, including EBITDA and Adjusted EBITDA, to assist in evaluating financial performance, specifically in evaluating the ability to service indebtedness and to fund ongoing capital expenditures. The Company’s credit facility includes covenants based upon Adjusted EBITDA. If Adjusted EBITDA declines below certain levels, the Company could go into default under the credit facility or be required to prepay the credit facility. Neither Adjusted EBITDA nor EBITDA should be considered in isolation or as a substitute for income (loss) from operations (as determined in accordance with GAAP).
For additional information regarding non-GAAP financial measures and a reconciliation of such measures to the most comparable financial measures under GAAP, please see below. The information in this press release should be read in conjunction with the financial statements and footnotes contained in our documents to be filed with the Securities and Exchange Commission.
About Xerium Technologies
Xerium Technologies, Inc. (NYSE:XRM - News) is a leading global manufacturer and supplier of two types of consumable products used primarily in the production of paper: clothing and roll covers. The Company, which operates around the world under a variety of brand names, utilizes a broad portfolio of patented and proprietary technologies to provide customers with tailored solutions and products integral to production, all designed to optimize performance and reduce operational costs. With 32 manufacturing facilities in 13 countries around the world, Xerium has approximately 3,300 employees.
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements involving risks and uncertainties, both known and unknown, that may cause actual results to differ materially from those indicated. These risks and uncertainties include the following items: (1) we are subject to significant risks as a result of the current global economic crisis and the associated unpredictable market conditions; (2) market improvement in our industry may occur more slowly than we anticipate or not at all; (3) our plans to reduce trapped cash, develop new products, and reduce costs may not be successful; (4) we may be unable to successfully resolve our credit issues, which would result in the acceleration of our debt and we anticipate we may not have sufficient cash available to pay our debt and continue operations; and (5) the other risks and uncertainties discussed elsewhere in this press release, our Form 10-K for the year ended December 31, 2008, and our subsequent SEC filings. If any of these risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary significantly from what we projected. Any forward-looking statement in this press release reflects our current views with respect to future events. We assume no obligation to publicly update or revise these forward-looking statements for any reason, whether as a result of new information, future events, or otherwise. As discussed above, we are subject to substantial risks and uncertainties related to the current economic downturn and our credit issues, and we encourage investors to refer to our SEC filings for additional information. Copies of these filings are available from the SEC and in the investor relations section of our website at www.xerium.com.
Selected Financial Data Follows
| Xerium Technologies, Inc. | |||||||||||||||||
| Selected Financial Data – (Unaudited) | |||||||||||||||||
| (dollars in thousands, except per share data) | |||||||||||||||||
| Consolidated Statements of Operations | |||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||
| 2009 | 2008 | 2009 | 2008 | ||||||||||||||
| Net sales | $ | 130,308 | $ | 159,307 | $ | 367,654 | $ | 488,687 | |||||||||
| Costs and expenses: | |||||||||||||||||
| Cost of products sold | 81,520 | 106,513 | 228,956 | 303,763 | |||||||||||||
| Selling | 16,991 | 20,125 | 49,574 | 62,437 | |||||||||||||
| General and administrative | 15,428 | 28,265 | 35,100 | 70,322 | |||||||||||||
| Restructuring and impairments | 1,754 | 3,612 | 2,894 | 6,862 | |||||||||||||
| Research and development | 2,708 | 2,910 | 8,168 | 9,109 | |||||||||||||
| Curtailment/settlement gains | — | (39,968 | ) | — | (39,968 | ) | |||||||||||
| 118,401 | 121,457 | 324,692 | 412,525 | ||||||||||||||
| Income from operations | 11,907 | 37,850 | 42,962 | 76,162 | |||||||||||||
| Interest expense | (16,651 | ) | (16,963 | ) | (48,899 | ) | (43,513 | ) | |||||||||
| Interest income | 226 | 733 | 947 | 1,296 | |||||||||||||
| Foreign exchange gain (loss) | 561 | 710 | (225 | ) | 3,344 | ||||||||||||
| Income (loss) before provision for income taxes | (3,957 | ) | 22,330 | (5,215 | ) | 37,289 | |||||||||||
| Provision for income taxes | 3,424 | 794 | 10,013 | 6,344 | |||||||||||||
| Net income (loss) | $ | (7,381 | ) | $ | 21,536 | $ | (15,228 | ) | $ | 30,945 | |||||||
| Net income (loss) per share: | |||||||||||||||||
| Basic | $ | (0.15 | ) | $ | 0.47 | $ | (0.31 | ) | $ | 0.67 | |||||||
| Diluted | $ | (0.15 | ) | $ | 0.46 | $ | (0.31 | ) | $ | 0.67 | |||||||
| Shares used in computing net income (loss) per share: | |||||||||||||||||
| Basic | 48,882,979 | 46,163,605 | 48,898,255 | 46,111,390 | |||||||||||||
| Diluted | 48,882,979 | 46,327,233 | 48,898,255 | 46,208,018 | |||||||||||||
|
Condensed Consolidated Selected Financial Data |
||||||||
|
Nine Months Ended
September 30, |
||||||||
| 2009 | 2008 | |||||||
| Balance sheet data (at end of period): | ||||||||
| Cash and cash equivalents | $ | 21,816 | $ | 18,449 | ||||
| Total assets | 784,456 | 832,188 | ||||||
| Senior debt | 591,471 | 620,232 | ||||||
| Total debt | 628,554 | 629,637 | ||||||
| Total stockholders’ equity (deficit) | (23,456 | ) | 10,699 | |||||
| Cash flow data: | ||||||||
| Net cash provided by operating activities | $ | 3,789 | $ | 52,834 | ||||
| Net cash used in investing activities | (8,659 | ) | (27,135 | ) | ||||
| Net cash used in financing activities | (9,314 | ) | (30,386 | ) | ||||
| Other financial data: | ||||||||
| Depreciation and amortization | $ | 30,769 | $ | 35,697 | ||||
| Capital expenditures | 13,970 | 29,145 | ||||||
NON-GAAP LIQUIDITY MEASURES
The Company uses EBITDA and Adjusted EBITDA as supplementary non-GAAP liquidity measures to assist in evaluating its liquidity and financial performance, specifically its ability to service indebtedness and to fund ongoing capital expenditures. The Company’s credit facility includes covenants based on Adjusted EBITDA. If the Company’s Adjusted EBITDA declines below certain levels, the Company will violate the covenants resulting in a default condition under the credit facility or be required to prepay the credit facility. Neither EBITDA nor Adjusted EBITDA should be considered in isolation or as a substitute for income (loss) from operations (as determined in accordance with GAAP).
The following table provides a reconciliation from net income (loss), which is the most directly comparable GAAP financial measure, to EBITDA and Adjusted EBITDA.
| Three Months Ended | ||||||||
| September 30, | ||||||||
| (in thousands) | 2009 | 2008 | ||||||
| Net income (loss) |
$ |
(7,381 |
) | $ | 21,536 | |||
| Income tax provision | 3,424 | 794 | ||||||
| Interest expense, net | 16,425 | 16,230 | ||||||
| Depreciation and amortization | 10,851 | 11,739 | ||||||
| EBITDA | 23,319 | 50,299 | ||||||
| Amendment/termination costs | — | 483 | ||||||
| Change in fair value of interest rate swaps |
(859 |
) |
450 | |||||
| Restructuring expenses | 87 | 1,817 | ||||||
| Inventory write-offs under restructuring programs | 104 | 199 | ||||||
| Non-cash compensation and related expenses | 778 | 500 | ||||||
| Non-cash impairment charges | 1,667 | 405 | ||||||
| Adjusted EBITDA | $ | 25,096 | $ | 54,153 | ||||
| Nine Months Ended | ||||||||
| September 30, | ||||||||
| (in thousands) | 2009 | 2008 | ||||||
| Net income (loss) |
$ |
(15,228 |
) | $ | 30,945 | |||
| Income tax provision | 10,013 | 6,344 | ||||||
| Interest expense, net | 47,952 | 42,217 | ||||||
| Depreciation and amortization | 30,769 | 35,697 | ||||||
| EBITDA | 73,506 | 115,203 | ||||||
| Unrealized foreign exchange gain on indebtedness, net | — |
(1,985 |
) |
|||||
| Amendment/termination costs | — | 6,480 | ||||||
| Change in fair value of interest rate swaps |
(1,654 |
) |
14,154 | |||||
| Change in fair value of other derivatives | — |
(2,126 |
) |
|||||
| Restructuring expenses | 1,227 | 5,000 | ||||||
| Inventory write-offs under restructuring programs | 349 | 199 | ||||||
| Growth program costs | — | 1,764 | ||||||
| Non-cash compensation and related expenses | 1,824 | 774 | ||||||
| Non-cash impairment charges | 1,667 | 472 | ||||||
| Adjusted EBITDA | $ | 76,919 | $ | 139,935 | ||||
SBG Investor Relations
Geoffrey Buscher, 508-532-1790
IR@xerium.com
Copyright © 2009 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials by posting, archiving in a public web site or database, or redistribution in a computer network is strictly forbidden.